Regulation of oxidized platelet lipidome: implications for coronary artery disease

Aims Hyperlipidaemia enhances susceptibility to thrombosis, while platelet oxidixed LDL (oxLDL) binding in acute coronary syndrome (ACS) correlates with activation status. This study explores the platelet lipidome in symptomatic coronary artery disease (CAD) patients and the functional consequences of the chemokine CXCL12 and its receptors CXCR-4/-7 on lipid uptake in platelets. Methods and results Platelet-oxLDL detected by flow cytometry was enhanced (P = 0.04) in CAD patients, moderately correlated with platelet CXCR7 surface expression (ρ = 0.39; P < 0.001), while inversely with CXCR4 (ρ = 0.35; P < 0.001). Platelet-oxLDL was elevated (P = 0.01) in ACS patients with angiographic evidence of intracoronary thrombi. Ex vivo analysis of intracoronary thrombi sections revealed oxLDL deposition in platelet-enriched areas verified by immunofluorescence confocal microscopy. LDL-oxLDL uptake enhanced reactive oxygen species, mitochondrial superoxide generation, intraplatelet LDL to oxLDL conversion, and lipid peroxidation, counteracted by SOD2-mimetic MnTMPyP. Lipidomic analysis revealed enhanced intraplatelet-oxidized phospholipids, cholesteryl esters, sphingomyelin, ceramides, di- and triacylglycerols, acylcarnitines in CAD patients compared with age-matched controls as ascertained by liquid chromatography hyphenated to high-resolution mass spectrometry. LDL-oxLDL induced degranulation, αIIbβ3-integrin activation, apoptosis, thrombin generation estimated by calibrated automated thrombinoscopy, and shape change verified by live imaging using scanning ion conductance microscopy. Further, LDL-oxLDL enhanced thrombus formation ex vivo and in vivo in mice (ferric chloride-induced carotid artery injury). LDL-oxLDL enhanced platelet CXCL12 release, differentially regulated CXCR4-CXCR7 surface exposure, while CXCL12 prompted LDL-oxLDL uptake and synergistically augmented the LDL-oxLDL-induced pro-oxidative, thrombogenic impact on platelet function. Conclusion An altered platelet lipidome might be associated with thrombotic disposition in CAD, a mechanism potentially regulated by CXCL12-CXCR4-CXCR7 axis.

[1]  Stuart M. Allen,et al.  Mapping the Human Platelet Lipidome Reveals Cytosolic Phospholipase A2 as a Regulator of Mitochondrial Bioenergetics during Activation , 2016, Cell metabolism.

[2]  Kim Ekroos,et al.  Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol , 2016, European heart journal.

[3]  T. Schäffer,et al.  Comparative morphology analysis of live blood platelets using scanning ion conductance and robotic dark-field microscopy , 2016, Platelets.

[4]  D. Rath.  Expression of SDF-1 Receptors CXCR4 and CXCR7 on Circulating Platelets of Patients with Acute Coronary Syndrome and Association with Left Ventricular Functional Recovery , 2016 .

[5]  M. Gawaz,et al.  Platelet-derived CXCL12 regulates monocyte function, survival, differentiation into macrophages and foam cells through differential involvement of CXCR4–CXCR7 , 2015, Cell Death and Disease.

[6]  E. Want,et al.  Perturbations in fatty acid metabolism and apoptosis are manifested in calcific coronary artery disease: An exploratory lipidomic study. , 2015, International journal of cardiology.

[7]  Ying Zhang,et al.  The Use of Variable Q1 Isolation Windows Improves Selectivity in LC-SWATH-MS Acquisition. , 2015, Journal of proteome research.

[8]  Min-Jeong Shin,et al.  Alteration in Metabolic Signature and Lipid Metabolism in Patients with Angina Pectoris and Myocardial Infarction , 2015, PloS one.

[9]  N. Yuldasheva,et al.  Oxidized LDL activates blood platelets through CD36/NOX2-mediated inhibition of the cGMP/protein kinase G signaling cascade. , 2015, Blood.

[10]  Masanori Arita,et al.  MS-DIAL: Data Independent MS/MS Deconvolution for Comprehensive Metabolome Analysis , 2015, Nature Methods.

[11]  A. Poole,et al.  SDF-1α is a novel autocrine activator of platelets operating through its receptor CXCR4 , 2015, Cellular signalling.

[12]  F. Violi,et al.  LDL oxidation by platelets propagates platelet activation via an oxidative stress-mediated mechanism. , 2014, Atherosclerosis.

[13]  M. Chatterjee,et al.  SDF‐1α induces differential trafficking of CXCR4‐CXCR7 involving cyclophilin A, CXCR7 ubiquitination and promotes platelet survival , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[14]  S. Watson,et al.  Platelet lipidomics: modern day perspective on lipid discovery and characterization in platelets. , 2014, Circulation research.

[15]  M. V. van Zandvoort,et al.  Activation of CXCR7 Limits Atherosclerosis and Improves Hyperlipidemia by Increasing Cholesterol Uptake in Adipose Tissue , 2014, Circulation.

[16]  M. Chatterjee,et al.  Expression of stromal cell-derived factor-1 receptors CXCR4 and CXCR7 on circulating platelets of patients with acute coronary syndrome and association with left ventricular functional recovery. , 2014, European heart journal.

[17]  M. Chatterjee,et al.  Platelet‐derived CXCL12 (SDF‐1α): basic mechanisms and clinical implications , 2013, Journal of thrombosis and haemostasis : JTH.

[18]  R. G. Salomon.  Structural Identification and Cardiovascular Activities of Oxidized Phospholipids , 2012, Circulation research.

[19]  T. Schönberger,et al.  Binding of Oxidized Low-Density Lipoprotein on Circulating Platelets Is increased in Patients With Acute Coronary Syndromes and Induces Platelet Adhesion to Vascular Wall In Vivo—Brief Report , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[20]  W. Kraus,et al.  Baseline metabolomic profiles predict cardiovascular events in patients at risk for coronary artery disease. , 2012, American heart journal.

[21]  T. Geisler,et al.  Plasma levels of stromal cell-derived factor-1 in patients with coronary artery disease: effect of clinical presentation and cardiovascular risk factors. , 2011, Atherosclerosis.

[22]  M. Gawaz,et al.  Platelet lipoprotein interplay: trigger of foam cell formation and driver of atherosclerosis. , 2008, Cardiovascular research.

[23]  J. Akkerman.  From low-density lipoprotein to platelet activation. , 2008, The international journal of biochemistry & cell biology.

[24]  S. Hazen,et al.  Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype , 2007, Nature Medicine.

[25]  M. Gawaz,et al.  Platelets in inflammation and atherogenesis. , 2005, The Journal of clinical investigation.

[26]  B. Strauss,et al.  Relationship of a comprehensive panel of plasma oxidized low-density lipoprotein markers to angiographic restenosis in patients undergoing percutaneous coronary intervention for stable angina. , 2005, American heart journal.

[27]  C. Weber.  Platelets and chemokines in atherosclerosis: partners in crime. , 2005, Circulation research.

[28]  Joseph Juliano,et al.  Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes. , 2003, Journal of the American College of Cardiology.

[29]  Zaverio M. Ruggeri,et al.  Platelets in atherothrombosis , 2002, Nature Medicine.